NRD
THC icon

Nebula Research & Development’s Tenet Healthcare THC Stock Holding History

Nebula Research & Development’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,919
Closed -$866K – 784
2025
Q2 		$866K Buy
+4,919
New +$740K 0.07% 452
2025
Q1 		– Sell
-6,023
Closed -$760K – 1137
2024
Q4 		$760K Buy
+6,023
New +$896K 0.09% 393
2023
Q4 		– Sell
-11,412
Closed -$752K – 873
2023
Q3 		$752K Buy
11,412
+4,575
+67% +$342K 0.4% 52
2023
Q2 		$556K Buy
+6,837
New +$487K 0.42% 113

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nebula Research & Development's THC Position: Q3 2025 in Review

Nebula Research & Development sold out of Tenet Healthcare (THC) in Q3 2025, closing a stake of 4,919 shares — an estimated $866K sold.

Nebula Research & Development first reported a position in THC in Q2 2023 and held it in 4 quarters. The position peaked at $866K in Q2 2025. 680 funds tracked by Wall St. Rank hold THC as of Q3 2025.

  • Nebula Research & Development reported no remaining Tenet Healthcare position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 4,919 Tenet Healthcare shares in Q3 2025, an estimated $866K.
  • Nebula Research & Development first reported a position in Tenet Healthcare in Q2 2023 and held it in 4 quarters.
  • Nebula Research & Development's Tenet Healthcare position peaked at $866K in Q2 2025.
  • 680 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.